The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 20, 2022

Filed:

Dec. 14, 2017
Applicant:

Zhejiang University, Hangzhou, CN;

Inventors:

Xufeng Lin, Hangzhou, CN;

Linxi Yao, Hangzhou, CN;

Shirui Chang, Hangzhou, CN;

Lei Wang, Hangzhou, CN;

Assignee:

ZHEJIANG UNIVERSITY, Hangzhou, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07F 9/50 (2006.01); B01J 31/24 (2006.01); C07C 17/06 (2006.01); C07C 23/18 (2006.01); C07C 25/22 (2006.01); C07C 37/62 (2006.01); C07C 39/17 (2006.01); C07C 39/42 (2006.01); C07C 41/09 (2006.01); C07C 43/247 (2006.01); C07F 15/00 (2006.01);
U.S. Cl.
CPC ...
C07F 9/5068 (2013.01); B01J 31/249 (2013.01); C07C 17/06 (2013.01); C07C 23/18 (2013.01); C07C 25/22 (2013.01); C07C 37/62 (2013.01); C07C 39/17 (2013.01); C07C 39/42 (2013.01); C07C 41/09 (2013.01); C07C 43/247 (2013.01); C07F 9/5022 (2013.01); C07F 9/5027 (2013.01); C07F 15/0053 (2013.01); C07F 15/0066 (2013.01); B01J 2531/16 (2013.01); B01J 2531/821 (2013.01); B01J 2531/824 (2013.01); C07C 2603/97 (2017.05);
Abstract

The present application discloses a 3,3,3',3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, an intermediate, a preparation method and uses thereof. The compound of phosphine ligand is a compound having a structure represented by formula I or formula II, or an enantiomer, a raceme, or diastereomer thereof. The phosphine ligand can be prepared via a preparation scheme in which the cheap and easily available 6,6′-dihydroxyl-3,3,3′,3′-tetramethyl-1,1′-spirobiindane is used as a raw material and the compound represented by formula III serves as the key intermediate. The new phosphine ligand developed by the present application can be used in catalytic organic reaction, in particular as a chiral phosphine ligand that is widely used in many asymmetric catalytic reactions including asymmetric hydrogenation and asymmetric allyl alkylation, and thus it has economic practicability and industrial application prospect.


Find Patent Forward Citations

Lin, Xufeng. (2022). Compound of 3,3,3',3′-tetramethyl-1,1′-spirobiindane-based phosphine ligand, and preparation method thereof (U.S. Patent No. 11530230). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11530230

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…